78
0
0
Like?
Please wait...
About This Project
We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Browse Other Projects on Experiment
Related Projects
Developing a novel oxysterol antibiotic to combat drug-resistant tuberculosis
Drug-resistant tuberculosis (TB) is a consistently growing threat to global health. We have developed Oxy291...
Predicting and improving persistence during exposure-based therapy for OCD
The efficacy of exposure-based therapies for obsessive compulsive disorder (OCD) is among the most well...
Mosquitoes as Flying Syringes: The Solution to Rapid Zika Monitoring
Yes, mosquitoes are flying syringes! They sample human blood as a normal part of their life cycle. We can...